The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
Norway
Oslo University Hospital, Oslo, Oslo County Haukeland University Hospital, Bergen, Vestland Age range
30 Years – 85 Years
Last updated January 2025